Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Enniatins |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01289
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Enniatins up-regulates the expression of DME CYP21A2 |
[1] |
Fipronil |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01302
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Fipronil up-regulates the expression of DME CYP21A2 |
[2] |
Pentabromophenol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00904
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Pentabromophenol up-regulates the expression of DME CYP21A2 |
[3] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
1-nitropyrene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00893
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
1-nitropyrene inhibits the expression of DME CYP21A2 |
[4] |
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME CYP21A2 |
[5] |
Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 up-regulates the expression of DME CYP21A2 |
[6] |
Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
3-Methylsulfonyl-dde |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01100
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Environmental Pollutant |
DME Modulation |
3-Methylsulfonyl-dde inhibits the expression of DME CYP21A2 |
[7] |
Galaxolide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00984
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Environmental Pollutant |
DME Modulation |
Galaxolide inhibits the drug-metabolizing activity of DME CYP21A2 |
[8] |
Mycotoxin |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Deoxynivalenol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01514
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Mycotoxin |
DME Modulation |
Deoxynivalenol up-regulates the expression of DME CYP21A2 |
[9] |
HT-2 toxin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01515
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Mycotoxin |
DME Modulation |
HT-2 toxin up-regulates the expression of DME CYP21A2 |
[9] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME CYP21A2 |
[10], [11] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME CYP21A2 |
[12] |
Ketoconazole |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00251
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Ketoconazole induces the drug-metabolizing activity of DME CYP21A2 |
[13] |
Obeticholic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00165
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Obeticholic acid inhibits the drug-metabolizing activity of DME CYP21A2 |
[14] |
Urethane |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Urethane inhibits the expression of DME CYP21A2 |
[15] |
Valproic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid inhibits the drug-metabolizing activity of DME CYP21A2 |
[16] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Resveratrol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00568
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Resveratrol inhibits the expression of DME CYP21A2 |
[17] |
Torcetrapib |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00627
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Torcetrapib up-regulates the expression of DME CYP21A2 |
[18] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Colforsin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00606
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Colforsin up-regulates the expression of DME CYP21A2 |
[19] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
3,3',4,5'-tetrahydroxystilbene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01133
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
3,3',4,5'-tetrahydroxystilbene inhibits the expression of DME CYP21A2 |
[20] |
Tributyltin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01491
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Tributyltin inhibits the expression of DME CYP21A2 |
[21] |
Other Chemical Compound(s) or Element(s) |
Cosmetic Additive |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
2-acetyltributylcitrate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01612
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Cosmetic Additive |
DME Modulation |
2-acetyltributylcitrate up-regulates the expression of DME CYP21A2 |
[19] |
|
|
|
|
|
|